PROCTER & GAMBLE HYGIENE & HEALTH CARE LTD. Q3 FY26 Results
PGHHQ3 FY26 ResultsAnnounced 30 Jan, 2:06 pm| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 1.3K | 9.7% | 1.1% |
| Total Income | 1.3K | 9.8% | 1.4% |
| Expenditure | 872.27 | 0.7% | 2.3% |
| PBT | 402.04 | 42.7% | 10.4% |
| Net Profit | 301.46 | 43.6% | 12.2% |
| OPM | 31.84% | 7.08pp | 4.76pp |
| NPM | 23.66% | 5.57pp | 2.30pp |
| EPS | 92.87 | 43.6% | 12.2% |
Procter & Gamble Hygiene and Health Care Ltd. Reports 1% Sales Growth and 12% PAT Increase for Q3 2025
30 Jan 2026 · 30 Jan, 2:17 pm
Summary
Procter & Gamble Hygiene and Health Care Ltd. announced its financial results for the quarter ended December 31, 2025. The company delivered sales of 21262 crore, reporting a growth of 1% versus year ago. Profit After Tax (PAT) for the quarter was 2301 crore, up 12% versus year ago, driven by operational efficiencies and favorable product price-mix.
Key Highlights
- 1
Sales up 1% versus year ago
- 2
PAT up 12% versus year ago
- 3
Operational efficiencies and favorable product price-mix drove the PAT growth
- 4
Company remains committed to its integrated growth strategy
Management Comments
Kumar Venkatasubramanian
We continued to invest to delight our consumers, reflecting in our stable performance. We remain committed to our integrated growth strategy, to drive balanced growth and value creation. This includes — a focused product portfolio of daily use categories where performance drives brand choice, superiority (of product performance, packaging, brand communication, retail execution and consumer and customer value), productivity, constructive disruption, and an agile and accountable organization.
Informational and educational content only. Not investment advice.